0

Dyslipidemia Collection
 101-120 of 341 Articles
Brief Communications |  6 July 1999
Postprandial Hypertriglyceridemia and Insulin Resistance in Normoglycemic First-Degree Relatives of Patients with Type 2 Diabetes
Mette Axelsen, PhD; Ulf Smith, MD, PhD; Jan W. Eriksson, MD, PhD; et al.
Ann Intern Med. 1999;131(1):27-31. doi:10.7326/0003-4819-131-1-199907060-00006
Articles |  6 April 1999
The Effect of Dietary ω-3 Fatty Acids on Coronary Atherosclerosis: A Randomized, Double-Blind, Placebo-Controlled Trial
Clemens von Schacky, MD; Peter Angerer, MD; Wolfgang Kothny, MD; et al.
Ann Intern Med. 1999;130(7):554-562. doi:10.7326/0003-4819-130-7-199904060-00003
Reviews |  2 March 1999
Clinical Effects of Raloxifene Hydrochloride in Women
Weerapan Khovidhunkit, MD; Dolores M. Shoback, MD
Ann Intern Med. 1999;130(5):431-439. doi:10.7326/0003-4819-130-5-199903020-00015
Reviews |  15 December 1998
Vulnerable Plaque: Pathobiology and Clinical Implications
Iftikhar J. Kullo, MD; William D. Edwards, MD; Robert S. Schwartz, MD
Ann Intern Med. 1998;129(12):1050-1060. doi:10.7326/0003-4819-129-12-199812150-00010
Articles |  1 November 1998
Effect of Pravastatin on Cardiovascular Events in Older Patients with Myocardial Infarction and Cholesterol Levels in the Average Range: Results of the Cholesterol and Recurrent Events (CARE) Trial
Sandra J. Lewis, MD; Lemuel A. Moye, MD, PhD; Frank M. Sacks, MD; et al.
Ann Intern Med. 1998;129(9):681-689. doi:10.7326/0003-4819-129-9-199811010-00002
Currents |  15 May 1998
Medical Libraries Today
L.M. Asta, MD
Ann Intern Med. 1998;128(10):881-882. doi:10.7326/0003-4819-128-10-199805150-00037
Ideas and Opinions |  15 March 1998
Cholesterol and Violence: Is There a Connection?
Beatrice A. Golomb, MD, PhD
Ann Intern Med. 1998;128(6):478-487. doi:10.7326/0003-4819-128-6-199803150-00009
Articles |  15 February 1998
The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; et al.
Ann Intern Med. 1998;128(4):262-269. doi:10.7326/0003-4819-128-4-199802150-00002
Brief Communications |  15 February 1998
The Effect of Estrogen Replacement Therapy on Plasma Nitric Oxide and Endothelin-1 Levels in Postmenopausal Women
Patricia J.M. Best, MD; Peter B. Berger, MD; Virginia M. Miller, PhD; et al.
Ann Intern Med. 1998;128(4):285-288. doi:10.7326/0003-4819-128-4-199802150-00006
Editorials |  1 June 1997
Is Hypertriglyceridemia a Risk Factor for Atherosclerotic Cardiovascular Disease? A Simple Question with a Complicated Answer
Henry N. Ginsberg, MD
Ann Intern Med. 1997;126(11):912-914. doi:10.7326/0003-4819-126-11-199706010-00012
Articles |  15 May 1997
Clarifying the Direct Relation between Total Cholesterol Levels and Death from Coronary Heart Disease in Older Persons
Maria-Chiara Corti, MD, MHS; Jack M. Guralnik, MD, PhD; Marcel E. Salive, MD, MPH; et al.
Ann Intern Med. 1997;126(10):753-760. doi:10.7326/0003-4819-126-10-199705150-00001
Articles |  15 December 1996
Effect of Apheresis of Low-Density Lipoprotein on Peripheral Vascular Disease in Hypercholesterolemic Patients with Coronary Artery Disease
Abraham A. Kroon, MD; Wim N.J.C. van Asten, PhD; Anton F.H. Stalenhoef, MD
Ann Intern Med. 1996;125(12):945-954. doi:10.7326/0003-4819-125-12-199612150-00001
Reviews |  15 December 1996
Dose-Response Characteristics of Cholesterol-Lowering Drug Therapies: Implications for Treatment
Gordon Schectman, MD; Jan Hiatt, PharmD
Ann Intern Med. 1996;125(12):990-1000. doi:10.7326/0003-4819-125-12-199612150-00011
Articles |  1 November 1996
Twenty-Year Dynamics of Serum Cholesterol Levels in the Middle-Aged Population of Eastern Finland
Pekka Jousilahti, MD, MSc; Erkki Vartiainen, MD, PhD; Jaakko Tuomilehto, MD, PhD, MPolSc; et al.
Ann Intern Med. 1996;125(9):713-722. doi:10.7326/0003-4819-125-9-199611010-00002
Articles |  1 October 1996
Effect of Combination Therapy with Lipid-Reducing Drugs in Patients with Coronary Heart Disease and “Normal” Cholesterol Levels: A Randomized, Placebo-Controlled Trial
Richard C. Pasternak, MD; Lisa E. Brown, MPH; Peter H. Stone, MD; et al.
Ann Intern Med. 1996;125(7):529-540. doi:10.7326/0003-4819-125-7-199610010-00001
Ideas and Opinions |  1 October 1996
Surrogate End Points in Clinical Trials: Are We Being Misled?
Thomas R. Fleming, PhD; David L. DeMets, PhD
Ann Intern Med. 1996;125(7):605-613. doi:10.7326/0003-4819-125-7-199610010-00011
Ideas and Opinions |  15 September 1996
Lowering Risk without Lowering Cholesterol: Implications for National Cholesterol Policy
Andrew L. Avins, MD, MPH; Warren S. Browner, MD, MPH
Ann Intern Med. 1996;125(6):502-506. doi:10.7326/0003-4819-125-6-199609150-00012
Ideas and Opinions |  15 May 1996
Cholesterol Reduction: Weighing the Benefits and Risks
J. Michael Gaziano, MD, MPH; Patricia R. Hebert, PhD; Charles H. Hennekens, MD, DrPH
Ann Intern Med. 1996;124(10):914-918. doi:10.7326/0003-4819-124-10-199605150-00009
Editorials |  15 May 1996
Lipid Formulations for Amphotericin B: Does the Emperor Need New Clothes?
John R. Graybill, MD
Ann Intern Med. 1996;124(10):921-923. doi:10.7326/0003-4819-124-10-199605150-00011
Articles |  15 March 1996
Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy: A Randomized, Controlled Clinical Trial
Howard N. Hodis, MD; Wendy J. Mack, PhD; Laurie LaBree, MS; et al.
Ann Intern Med. 1996;124(6):548-556. doi:10.7326/0003-4819-124-6-199603150-00002
Advertisement

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)